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Richard B. Devereux, MD,§ Eva M. Staal, MD, PHD, Simon Ray, MD,¶
Kristian Wachtell, MD, PHD,# Eva Gerdts, MD, PHD*†
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and Copenhagen, Denmark
O B J E C T I V E S This study sought to assess the impact of valvuloarterial impedance on left
ventricular (LV) myocardial systolic function in asymptomatic aortic valve stenosis (AS).
B A C KG ROUND In atherosclerotic AS, LV global load consists of combined valvular and arterial
resistance to LV ejection. Global load signiﬁcantly impacts LV ejection fraction (EF) in symptomatic AS,
but less is known about its effect on LV myocardial function in asymptomatic AS.
METHOD S Echocardiograms in 1,591 patients with asymptomatic AS (67  10 years, 51%
hypertensive) at baseline in the SEAS (Simvastatin Ezetimibe in Aortic Stenosis) study evaluating
placebo-controlled combined simvastatin and ezetimibe treatment in AS were used to assess LV global
load as valvuloarterial impedance and LV myocardial function as stress-corrected midwall shortening.
The study population was divided into tertiles of global load. Stress-corrected midwall shortening was
considered low if 87% in men and90% in women. Low-ﬂow AS was deﬁned as stroke volume index
22 ml/m2.04.
R E S U L T S Energy loss index decreased (0.85 cm2/m2 vs. 0.77 and 0.75 cm2/m2) and the prevalence
of low stress-corrected midwall shortening increased (10% vs. 26% and 63%) with increasing LV global
load (all p  0.001). The EF was low in only 2% of patients. Patients with low-ﬂow AS had higher LV
global load and more often low midwall shortening than those with normal-ﬂow AS (9.66  2.23 mm
Hg/ml·m2.04 and 77%, vs. 6.38  2.04 mm Hg/ml·m2.04 and 30%, respectively, p  0.001). In logistic
regression analysis, LV global load was a main predictor of low stress-corrected midwall shortening
independent of male sex, concentric LV geometry, LV hypertrophy (all p  0.001), concomitant
hypertension, and aortic regurgitation.
CONC L U S I O N S LV global load impacts LV myocardial function in asymptomatic AS independent
of other main covariates of LV systolic function. LV myocardial systolic dysfunction is common in
asymptomatic AS in particular in patients with low-ﬂow AS and increased valvuloarterial afterload,
whereas EF is generally preserved. (An Investigational Drug on Clinical Outcomes in Patients With Aortic
Stenosis [Narrowing of the Major Blood Vessel of the Heart]; NCT00092677) (J Am Coll Cardiol Img
2009;2:390–9) © 2009 by the American College of Cardiology Foundation
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391ecent publications have suggested that aortic
valve stenosis (AS) should not be regarded as an
isolated valvular disease, but as part of an ath-
erosclerotic process involving both the aortic
alve and the large arteries (1,2). Thus, in atheroscle-
otic AS, left ventricular (LV) load reflects combined
alvular and arterial resistance to LV ejection, which
ay be assessed by valvuloarterial impedance (2). The
mpact of combined valvuloarterial impedance on LV
jection fraction (EF) has been shown in patients with
evere AS, but has so far not been studied in asymp-
omatic stages of AS (2).
See page 400
It is well known that EF may remain normal
uring chronic pressure overload despite reduced
yocardial contractility by use of the preload re-
erve (3) or by changes in LV geometry (4), and
espite impaired LV long-axis function shown by
issue Doppler (5). In essential hypertension, LV
idwall shortening, reflecting myocardial function
nd not merely endocardial displacement, has been
uggested as a more sensitive marker of LV systolic
unction (6) and has proven prognostic value (7).
urthermore, stress-corrected LV midwall shorten-
ng has recently been shown to be independently
ssociated with the presence of symptoms in symp-
omatic aortic stenosis (8). Among patients with
evere AS, a group characterized by low-flow low-
radient and reduced survival despite preserved EF
as recently been described (9). It is currently
nknown whether this phenomenon may be present
lso in asymptomatic and milder degrees of AS.
Thus, the aim of the present analysis was to
valuate the impact of global LV load on LV systolic
unction measured as EF and stress-corrected midwall
hortening in asymptomatic patients with normal
ersus low-flow AS recruited in the SEAS (Simvasta-
in Ezetimibe in Aortic Stenosis) study.
E T H O D S
tudy population. The SEAS study randomized
,873 patients (ages 45 to 85 years, 38.6% women)
Department of Cardiology, The Heart Center, Rigshospitalet, Copenhag
ortic Stenosis) Echocardiography Core Laboratory was supported b
artnership between Merck Co., Inc., and the Schering-Plough Corporatio
or occasional lectures at scientific symposia sponsored by Merck/Scheri
cientific Steering Committee in the SEAS study. Dr. Ray has receive
peakers’ bureau appointments. Dr. Devereux has received honoraria fromanuscript received May 28, 2008; revised manuscript received December 1ith asymptomatic AS to a 4-year, double-blind,
lacebo-controlled treatment with combined simva-
tatin and ezetimibe versus placebo to evaluate the
ffect on AS progression and cardiovascular morbidity
nd mortality (10). Eligible patients had asymptom-
tic AS defined as aortic valve thickening accompa-
ied by a peak transaortic velocity2.5 and4.0 m/s
easured at the field centers. Patients with coronary
eart disease, heart failure, diabetes, history of stroke
r peripheral vascular disease, clinically significant
itral valve disease, severe or predominant aortic
egurgitation, rheumatic valvular disease, aortic valve
rosthesis or renal insufficiency, and patients already
n lipid-lowering therapy were not included in the
EAS study. Baseline patient characteristics and
EAS study design have recently been published (10).
he present population included the 1,591 of the
,873 SEAS patients included in the SEAS study in
hom LV global load could be calculated from the
aseline (pre-randomization) echocardiogram.
ompared with the nonselected patients, the
resent study population did not differ in
ge, sex, concomitant hypertension, or se-
erity of AS. Hypertension was defined as
istory of hypertension reported by the
ttending physician. Blood pressure was
easured at clinical visits. Pulse pressure
as defined as the difference of systolic to
iastolic blood pressure. The SEAS study
as approved by the regional ethics com-
ittees in all participating countries. All
atients gave written informed consent to
articipate in the SEAS study.
chocardiographic measurements. Baseline exami-
ations were performed at the 173 SEAS study sites
ollowing a standard protocol. Images were stored
n VHS video tapes, CDs, or MO disks and
orwarded for final reading to the SEAS Echocar-
iography Core Laboratory at Haukeland Univer-
ity Hospital, Bergen, Norway. The SEAS echocar-
iographic protocol has recently been published (11).
ll study echocardiograms were initially read by a
unior member of the SEAS Echocardiography Core
aboratory staff and later proofread by a senior inves-
igator; 93% of final readings were performed by 1
Denmark. The SEAS (Simvastatin Ezetimibe in
SP Singapore Company, LLC, Singapore, a
rs. Wachtell and Gerdts have received honoraria
lough Pharmaceuticals and as members of the
yments for recruitment into the study and for
d served as a consultant for Merck & Co., Inc.
A B B
A N D
AS
CI c
EF e
LV
ROC
charaen,
y M
n. D
ng-P
d pa
an9, 2008, accepted December 24, 2008.R E V I A T I O N S
A C R O N YM S
aortic stenosis
onfidence interval
jection fraction
left ventricle
receiver-operator
h
d
A
U
A
g
m
t
b
w
I
H
I
o
w
p
f
s
m
d
C
m
c

w
a
c
f
f
A
i
p
b
t
p
t
A
a
p
n
n
s
A
w
a
d
p
g
R
w
fi
S
o
r
i
u
2
t
v
c
g
b
y
w
s
c
a
a
g
c
c
d
e
a
v
t
a
s
o
u
R
P
s
p
c
m
t
a
a
t
A
a
m
e
L
a
s
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 4 , 2 0 0 9
A P R I L 2 0 0 9 : 3 9 0 – 9
Cramariuc et al.
Global Afterload and Systolic Function in AS
392ighly experienced reader (E.G.). All reading was
one using off-line digital workstations with Image
rena software (TomTec Imaging Systems GmbH,
nterschleissheim, Germany).
ssessment of AS severity. The Doppler echocardio-
raphic assessment of the severity of AS included
easurement of peak and mean transaortic veloci-
ies and gradients, and energy loss index calculated
y a previously validated formula (12). Severe AS
as defined as energy loss index 0.55 cm2/m2 (2).
n severe AS, a mean transaortic gradient 30 mm
g was considered low (13).
ndices of LV systolic function. The primary measure
f LV systolic function was stress-corrected mid-
all shortening assessed as the ratio of actual to
redicted midwall shortening for the actual circum-
erential end-systolic stress (14). The LV midwall
hortening was calculated based on 2-dimensional
easurements according to the current recommen-
ations for cardiac chamber quantification (15).
ircumferential end-systolic stress was calculated at
idwall using a cylindrical model (16). Stress-
orrected midwall shortening was considered low if
87% in men and 90% in women (17). The EF
as measured by the biplane method of disks (15)
nd considered low if 50%.
Stroke volume was measured using the Teichholz
orrection of the cube formula (18) and normalized
or height at the allometric power of 2.04 to account
or its nonlinear variation with body size (19). The
S was defined as low flow when stroke volume
ndex was 22 ml/m2.04, which corresponds to the
revious cutoff of 35 ml/m2 when correcting for
ody surface area, and normal flow if above this
hreshold (9). The ratio of stroke volume index to
ulse pressure was used as an indirect measure of
otal systemic arterial compliance (20).
ssessment of global LV load. Global LV load was
ssessed by the valvuloarterial impedance as pro-
osed by Briand et al. (2), taking into account the
et mean transaortic gradient and thus the phe-
omenon of pressure recovery downstream to the
tenotic valve (21):
Valvuloarterial impedance
 (systolic arterial pressure
 mean net transaortic gradient)
/(stroke volume/height2.04)
ssessment of LV geometry. The LV dimensions
ere measured in the 2-dimensional parasternal long-
xis view following the American Society of Echocar-
iography guidelines (15). Left ventricular hypertro-
hy was assessed by LV mass/height2.7 (cutoffs 46.7 3/m2.7 in women and 49.2 g/m2.7 in men) (22).
elative wall thickness (end-diastolic posterior LV
all thickness/end-diastolic LV internal radius) de-
ned concentric LV geometry if 0.43.
tatistical analysis. Reproducibility of measurements
f midwall shortening was assessed by intraclass cor-
elation coefficients. The study population was divided
nto tertiles of global LV load. The chi-square test was
sed to compare categorical variables and full-factorial
-way analysis of variance with the Sidak post hoc test
o compare continuous variables, as appropriate. Bi-
ariate correlations were assessed using the Pearson
orrelation coefficients with log transformation of LV
lobal load to satisfy the assumption of normal distri-
ution. Receiver-operator characteristic (ROC) anal-
sis was used to identify the value of global LV load
ith best sensitivity and specificity in predicting low
tress-corrected midwall shortening. The independent
ovariates of low stress-corrected midwall shortening
nd EF were identified by binary logistic regression
nalysis with forced entry of covariates. Results are
iven as Wald statistic and odds ratios with 95%
onfidence intervals (CIs). A weighted risk score was
alculated based on regression coefficients of indepen-
ent covariates of low stress-corrected midwall short-
ning identified in multivariate logistic regression
nalysis. The individual beta coefficients were con-
erted into scores (multiplied by 10 and rounded off to
he nearest whole number) and added to obtain an
ggregated score. The discriminative power of the risk
core was assessed with a ROC curve. A 2-tailed value
f p  0.05 was considered significant in both
nivariate and multivariate analyses.
E S U L T S
atient characteristics. Patient age, heart rate, and
ystolic and diastolic blood pressure, and the pro-
ortions of women and hypertensive patients in-
reased with higher global LV load, whereas body
ass index decreased (all p 0.01) (Table 1). All of
he 51% of hypertensive patients were taking an
ntihypertensive treatment. The average number of
ntihypertensive drugs and the number of patients
aking beta-blockers did not differ between tertiles.
S severity and systemic arterial compliance. Peak
nd mean transvalvular gradients, including the net
ean transvalvular gradient, increased, whereas en-
rgy loss index decreased in higher tertiles of global
V load (all p  0.001) (Table 2). Low systemic
rterial compliance was present in 40% of the total
tudy population and increased significantly from
% in tertile 1 to 35% in tertile 2 and 83% in tertile
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393(p  0.001) (Table 2). Global LV load was
ignificantly correlated with the energy loss index
r  0.13 and 0.16) and with systemic arterial
ompliance (r  0.78 and 0.80) both in nor-
otensive and hypertensive patients, respectively,
ll p  0.001.
ow-ﬂow AS. Among the 359 patients with energy
oss index 0.55 cm2/m2 in the present study
opulation, 100 (28%) had a low stroke volume
ndex (22 ml/m2.04). These patients had excessive
lobal LV load compared with patients with se-
erely reduced energy loss index but normal-flow
Table 1. Clinical and Biochemical Characteristics of Patients in t
All
(n  1,591)
Age (yrs) 67 10
Women (%) 39
Body surface area (m2) 1.89 0.20
Body mass index (kg/m2) 26.8 4.3
Systolic blood pressure (mm Hg) 145 20
Diastolic blood pressure (mm Hg) 82 10
Concomitant hypertension (%) 51
Heart rate (beats/min) 66 12
Total cholesterol (mmol/l) 5.73 1.02
LDL cholesterol (mmol/l) 3.57 0.91
HDL cholesterol (mmol/l) 1.51 0.43
Triglycerides (mmol/l) 1.42 0.67
C-reactive protein (mg/dl) 0.43 0.85
Creatinine (mol/l) 93.39 15.62
Data are mean  SD or percentage. *p  0.001 between tertiles. †p  0.01 be
HDL  high-density lipoprotein; LDL  low-density lipoprotein; LV  left ven
Table 2. Indices of AS Severity and LV Systolic Function in the
All
(n  1,591)
Peak transaortic gradient (mm Hg) 39 14
Mean transaortic gradient (mm Hg) 23 9
Net mean transaortic gradient (mm Hg) 19 8
Energy loss index (cm2/m2) 0.79 0.34
Aortic valve area (cm2) 1.28 0.47
Aortic valve area index (cm2/m2) 0.67 0.23
Global LV load (mm Hg/ml·m2.04) 6.59 2.20
Global LV load (mm Hg/ml·m2) 4.19 1.38
Stroke volume index (ml/m2.04) 27 7
Systemic arterial compliance (ml/m2.04·mm Hg) 0.45 0.18
Circumferential end-systolic stress (dyne/cm2) 112 32
Ejection fraction (%) 66 7
Midwall shortening (%) 17.0 3.3
Stress-corrected midwall shortening (%) 97.3 19.5
Data are mean  SD. *p  0.001 between tertiles. †p  0.01 between tertiles.
AS  aortic stenosis; LV  left ventricular.S (9.66  2.23 mm Hg/ml·m2.04 vs. 6.01  1.22
m Hg/ml·m2.04, p 0.001) or compared with the
emaining population (Table 3). They also included
ore women, had a higher heart rate, had lower LV
olumes and LV mass index, and had higher rela-
ive wall thickness (Table 3) and thus more con-
entric geometry (43% vs. 17%) (all p  0.05).
V Systolic Function
revalence of low LV systolic function. Reproducibil-
ty of measurement of midwall shortening was
ested in a subset of 98 patients. The reproducibility
Total Study Population and Divided in Tertiles of Global LV Load
Tertile 1
(LV Load <5.50)
(n  531)
Tertile 2
(5.50 < LV Load <7.04)
(n  530)
66 10* 67 9
37† 35
1.91 0.20* 1.91 0.19
27.6 4.4* 27.0 4.3
140 19* 146 20
81 10* 82 10
46† 51
64 11* 65 11
5.63 1.02‡ 5.77 0.98
3.51 0.90 3.60 0.87
1.46 0.43* 1.51 0.43
1.44 0.71 1.44 0.65
0.44 1.09 0.42 0.59
93.23 15.25 93.76 15.78
en tertiles. ‡p  0.05 between tertiles.
lar.
le Population and in Tertiles of Global LV Load
Tertile 1
(LV Load <5.50)
(n  531)
Tertile 2
(5.50 < LV Load <7.04)
(n  530)
37 13* 40 13
21 8* 23 8
17 7* 19 8
0.85 0.35* 0.77 0.33
1.38 0.49* 1.26 0.48
0.72 0.24* 0.66 0.23
4.61 0.63 6.21 0.45
2.98 0.44 3.96 0.39
34 6* 27 4
0.62 0.18* 0.43 0.10
112 32† 115 33
67 6 66 7
19.2 2.9* 17.1 2.6
109.5 17.0* 98.1 15.9he
Tertile 3
(LV Load >7.04)
(n  530)
69 9
44
1.86 0.20
25.9 4.0
149 20
84 10
56
68 12
5.80 1.05
3.61 0.95
1.56 0.42
1.37 0.66
0.43 0.81
93.17 15.87
tweWho
Tertile 3
(LV Load >7.04)
(n  530)
41 14
24 9
20 8
0.75 0.31
1.19 0.42
0.64 0.21
8.94 2.07
5.62 1.34
20 4
0.31 0.09
109 32
66 7
14.8 2.8
84.1 16.6
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394as excellent, with an intraclass correlation coeffi-
ient 0.92 (95% CI: 0.87 to 0.96) for intraobserver
ariability, and 0.98 (95% CI: 0.89 to 0.99) for
nterobserver variability (both p  0.001). In the
otal study population, 33% of patients had low
tress-corrected midwall shortening, whereas only
% had low EF. Among patients with low stress-
orrected midwall shortening, only 3% also had low
10
26
63
231
Low LV Systolic
function (%)
Low scMWS Low EF
p < 0.001
Tertile 1
Tertile 2
Tertile 3
ystolic Function in Tertiles of Global Load
of low stress-corrected midwall shortening (scMWS) and low
ction (EF) in tertiles of global left ventricular (LV) load. p  0.001
Echocardiographic Characteristics of Patients With Low-Flow AS
d Energy Loss Index Versus the Remaining Study Population
Stroke Volume Index
<22 ml/m2.04 and
Energy Loss Index
<0.55 cm2/m2
(n  100)
Stroke Volume Index
>22 ml/m2.04 and/or
Energy Loss Index
>0.55 cm2/m2
(n  1,491)
69 9 67 10
49† 38
2) 26.3 3.9 26.9 4.3
68 10† 66 12
e (ml) 94 33* 112 45
(ml) 33 16* 39 22
41 12* 46 15
(%) 44 12* 35 9
ent (mm Hg) 29 8* 22 8
adient (mm Hg) 25 8* 18 8
/m2) 0.45 0.07* 0.81 0.34
g/ml·m2.04) 9.66 2.23* 6.38 2.04
l/m2.04) 19 3* 28 7
65 7 66 7
ll shortening (%) 78.5 14.6* 98.5 19.1
0.001 and †p  0.05 between the 2 groups.
2.9
between tertiles of global LV load.F. The EF did not differ between tertiles of global
V load, whereas stress-corrected midwall shorten-
ng and stroke volume index decreased significantly
ith increasing load (p  0.001) (Table 2). Preva-
ence of low stress-corrected midwall shortening
ncreased with increasing global load, reaching 63%
n the highest tertile (Fig. 1). Adjustment for LV
eometry did not change the results.
mpact of global LV load on systolic function in the
eneral study population. Lower stress-corrected
idwall shortening was significantly associated
ith higher global LV load (r0.60, p 0.001),
his negative correlation being present both in
atients with normal and in patients with low
tress-corrected midwall shortening (Fig. 2). In
OC analysis, valvuloarterial impedance  7 mm
g/ml·m2.04 (corresponding to 4.48 mm Hg/ml·m2
hen indexing stroke volume for body surface area)
as the threshold value with the best specificity
80%) and sensitivity (65%) in predicting low stress-
orrected midwall shortening (area under the curve
.803, p  0.001) (Fig. 3). A low but statisti-
ally significant univariate correlation was also
ound between EF and global LV load (r  0.07,
 0.05).
In binary logistic regression analysis, including
lobal LV load, and indicator variables for sex,
resence of aortic regurgitation, LV hypertrophy,
oncentric LV geometry, and hypertension as inde-
endent variables, the independent covariates of
ow stress-corrected midwall shortening were:
igher global LV load, male sex, concentric LV
eometry, and LV hypertrophy (all p  0.001, 2
og likelihood ratio: 1,080) (Table 4). Results did
ot change in additional models including age and
eart rate among the covariates. Separate analysis in
atients with low and normal stroke volume showed
hat global LV load as well as concentric LV
eometry and LV hypertrophy all were independent
ovariates of low stress-corrected midwall shorten-
ng in both subpopulations (p  0.001). Further
eplacing global LV load with an indicator variable
or load 7 mm Hg/ml·m2.04 in a final model (–2
og likelihood ratio: 1,219) identified high global
oad and concentric LV geometry as major covari-
tes of low stress-corrected midwall shortening,
dds ratios 10.84 (95% CI: 7.60 to 15.46) and 13.15
95% CI: 8.73 to 19.80) per 1% lower stress-
orrected midwall shortening, respectively (both
 0.001). Male sex (OR 1.52, 95% CI: 1.13 to
.04) and presence of LV hypertrophy (OR 6.23,0
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ejection fraTable 3. Clinical and
and Severely Reduce
Age (yrs)
Women (%)
Body mass index (kg/m
Heart rate (beats/min)
End-diastolic LV volum
End-systolic LV volume
LV mass index (g/m2.7)
Relative wall thickness
Mean transaortic gradi
Net mean transaortic gr
Energy loss index (cm2
Global LV load (mm H
Stroke volume index (m
Ejection fraction (%)
Stress-corrected midwa
Data are mean  SD. *p 5% CI: 4.38 to 8.87, both p  0.01) contributed
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395ess, whereas the presence of aortic regurgitation
nd hypertension were not significant covariates.
A risk score was calculated based on the beta
oefficients in this final multivariate logistic regres-
ion model: Risk score  12  (high global LV
oad)  2  (male sex)  13  (concentric LV
eometry)  (9  LV hypertrophy). For each
arameter included in the score, a value of 1 was
ssigned if the variable was present or 0 if it was
bsent. Thus, the individual risk score varied in our
tudy population between 0 and 36 points. Based on
he ROC curve analysis, the optimal cutoff point for
he prediction of low stress-corrected midwall
hortening was a score of 14 points (area under the
urve 0.87, specificity and sensitivity 86% and 67%,
espectively) (Fig. 3).
In similar analyses, LV hypertrophy was the only
ndependent covariate of low EF, odds ratio 5.27
or the presence of LV hypertrophy, (95% CI: 2.13
o 13.07, p  0.001), whereas neither global LV
oad nor global load 7 mm Hg/ml·m2.04 were
ndependent covariates of EF.
mpact of global LV load on systolic function in low-
ow AS. Low stress-corrected midwall shortening
as present in 77% of patients with low-flow severe
S compared with 30% in the remaining study
opulation. Stress-corrected midwall shortening
as lower even after correction for age, sex, con-
omitant hypertension, and LV geometry (adjusted
eans 78.4% vs. 98.7%, p  0.001), whereas EF
as in the normal range and comparable to what
as found in the total population (Table 3). Lower
tress-corrected midwall shortening was stronger
ssociated with higher global LV load in this
ubgroup than in patients with normal-flow severe
S (Fig. 4). Despite severely reduced energy loss
ndex, 56% of these patients had mean transaortic
radient30 mm Hg, and the average mean gradient
n this group was 29 mm Hg (Table 3).
I S C U S S I O N
his study shows that increased global LV load has
significant negative impact on LV midwall me-
hanics in patients with asymptomatic AS, in spite
f normal EF. Our findings add to previous knowl-
dge by showing that: 1) increased global LV load
s detrimental to LV myocardial systolic function in
symptomatic AS; 2) high global LV load and high
revalence of myocardial systolic dysfunction are
resent particularly in patients with low-flow AS
i.e., low LV output despite preserved LV ejection
raction) and severely reduced energy loss index;r=-0.60, n=1591
SEE=15.67
y=-0.60*x+2.99
p<0.001
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Figure 2. Midwall Shortening in Correlation With Global Load
Global left ventricular (LV) load (log-transformed global load, horizontal axis) has strong
negative relations with stress-corrected midwall shortening (vertical axis) in the whole pop-
ulation (A) and in patients with normal (B) or with low (C) left ventricular systolic function.
(A) The x reference line indicates the value of log-transformed global LV load with best sen-
sitivity and speciﬁcity in predicting low stress-corrected midwall shortening. Pearson correla-
tion coefﬁcient r  0.60, p  0.001. (B, C) The x reference line indicates the mean value
of log-transformed global load in patients with normal/low stress-corrected midwall shorten-
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396nd 3) subclinical LV myocardial systolic dysfunc-
ion cannot be predicted from assessment of EF.
lobal LV load. Aortic stenosis is frequently associated
ith reduced arterial compliance, as recently reported
2). This was also the case in the SEAS population,
hich included older patients with degenerative
symptomatic AS, of whom 51% were on antihyper-
ensive treatment, from which a high prevalence of
educed systemic arterial compliance is to be expected.
n increased arterial load influences both the diagno-
is and the outcome of patients with AS (1,23). As
hown by our results, valvuloarterial impedance is
ighly correlated to systemic arterial compliance and
o the severity of AS assessed by the energy loss index
oth in hypertensive and in normotensive individuals,
nd thus represents an adequate expression for the
ombined valvular and arterial load present in AS. We
howed that increased valvuloarterial impedance sig-
ificantly affects stress-corrected midwall shortening,
dding support for the recent proposal to assess both
he valvular and the arterial disease in AS (1).
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Figure 3. Predictive Cutoffs of Low Midwall Shortening
Receiver-operator characteristic (ROC) curves for the cutoff level of glo
sensitivity and speciﬁcity in predicting low-stress corrected midwall sho
(14 points) identiﬁed by ROC analysis are indicated by arrows. AUC 
f Low Stress-Corrected Midwall Shortening in Multivariate
nalysis
Wald
Statistic p Value
Odds Ratio
(95% Conﬁdence Interval)
226.34 0.001 2.47 (2.19–2.78)
12.17 0.001 1.77 (1.29–2.44)
ry 91.05 0.001 8.21 (5.33–12.65)
148.52 0.001 10.60 (7.25–15.50)
0.01 0.970 0.99 (0.73–1.36)
sion 0.68 0.408 0.88 (0.65–1.19)sow-ﬂow AS. Among the challenging patients with
ow-flow severe AS (24,25), a group with low
ransvalvular gradient, paradoxically preserved EF
nd reduced survival, who seemed to benefit more
rom surgical than medical treatment, has recently
een described (9). The criteria for this condition
ere also identified within the present population
ccurring in 28% of patients with asymptomatic AS
nd severely reduced energy loss index, which is
onsistent with the 35% reported by Hachicha et al.
9) in a study of patients with severe AS. In
ccordance with their results, the pattern of low-
ow severe AS in the present study was associated
ith more pronounced LV concentric remodeling,
maller LV cavity, increased global LV load as
eflected by higher valvuloarterial impedance, and
educed midwall shortening. The study by
achicha et al. (9), however, had several limita-
ions, including the retrospective design as well as
he unknown status of symptoms at baseline.
ence, a substantial proportion of patients included
n this previous study were probably symptomatic at
aseline. The present prospective study confirms
hat an important proportion of asymptomatic pa-
ients with severe AS and preserved EF may none-
heless present with a low-flow state and thus a low
radient, which may in turn lead to an underesti-
ation of the disease severity. Furthermore, this
tudy confirms that these patients are, in fact, at a
ore advanced stage of the disease with more
everely impaired intrinsic myocardial function.
his finding may explain the reduced survival ob-
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14 points
eft ventricular (LV) load (A) and of the clinical risk score (B) with best
ing. The cutoffs of global LV load (7 mm Hg/ml·m2.04) and risk score
under the curve with the 95% conﬁdence interval.B
bal l
rtenTable 4. Covariates o
Logistic Regression A
Variables
Global LV load
Male gender
Concentric LV geomet
LV hypertrophy
Aortic regurgitation
Concomitant hypertenerved in the study by Hachicha et al. (9).
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397mpact of global LV load on LV systolic function. The
resent study is the first to show that LV myocardial
ystolic function often is reduced in asymptomatic
tages of AS with preserved EF. Stress-corrected
idwall shortening was recently shown to be inde-
endently associated with the presence of symptoms
n symptomatic aortic stenosis (8). Our result adds to
his previous observation by showing that low stress-
orrected midwall shortening can be found in 33% of
atients with asymptomatic AS, and is most frequent
n low-flow AS (77% in our study). Furthermore,
tress-corrected midwall shortening decreased signifi-
antly and proportionally with higher global LV load,
ven after adjustment for LV geometry. The influence
f high load on myocardial function was in particular
uch stronger in patients with low-flow AS than in
hose with normal-flow severe AS (r 0.51 vs.
0.34, p  0.001). Considering that the normal LV
s functionally matched to its load (26), we show that
n asymptomatic AS a mismatch between load and
V systolic function frequently occurs.
The impact of global LV load on LVEF was
reviously published by Briand et al. (2) in 208
atients with moderate to severe, mostly symptom-
tic AS, and several comorbidities (coronary artery
isease in 59%, previous myocardial infarction in
8%, and diabetes in 23% of patients). We extend
his previous observation by showing that, in
symptomatic stages of AS, increased global LV
oad significantly impacts LV myocardial systolic
unction, whereas no independent association with
ow EF was found. As shown by our multivariate
nalyses, increased global LV load influenced
normal-flow AS
r=-0.34, n=2
SEE=15.9
y=-0.34*x-5
p<0.001
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Figure 4. Load and Function in Low-Flow Aortic Stenosis
Global left ventricular (LV) load (log-transformed global load, horizo
wall shortening (vertical axis) in patients with low-ﬂow severe aortic
right panel) than in patients with normal-ﬂow severe AS (Pearson ctress-corrected midwall shortening independent of iV geometry, LV hypertrophy, and sex, and the
resence of an valvuloarterial index 7 mm Hg/
l·m2.04, the value most discriminative in predict-
ng low stress-corrected midwall shortening, in-
reased the probability of having low stress-
orrected midwall shortening by 51%, adjusting for
he other variables in the model. Of note, this
hreshold value is about 10% lower than the previ-
usly reported valvuloarterial impedance threshold
or low EF of 5 mm Hg/ml·m2 (2) because indexing
or height2.04 yields a higher value than indexing for
ody surface area.
EF was normal in the overwhelming majority of
symptomatic AS patients, and in multivariate
nalyses, low EF was only associated with LV
ypertrophy, not with global LV load. This finding
s in accordance with previous knowledge that EF
eflects LV endocardial displacement and not myo-
ardial function and that EF often fails to diagnose
V myocardial systolic dysfunction (27,28). Low
F, as shown by Hein et al. (28) in biopsies from
S patients, is associated with myocyte death and
brosis, which occur when myocardial compensa-
ory mechanisms are exhausted and may continue
ven after excessive afterload disappears because of
ortic valve replacement. Based on our results, we
peculate that myocardial systolic dysfunction, re-
ected by low stress-corrected midwall shortening,
ay occur at earlier stages of degeneration, which
re dominated by increased density of cellular mi-
rotubule network (29) and hypertrophy (28) in
esponse to increased global load.
linical implications. These results have potentially
r=-0.51, n=100
SEE=12.68
y=-0.51*x-5.82
p<0.001
Global LV load
low-flow AS
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axis) has a stronger negative relation with stress-corrected mid-
nosis (AS) (Pearson correlation coefﬁcient r  0.51, p  0.001,
lation coefﬁcient r  0.34, p  0.001, left panel).59
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398ients with asymptomatic AS. LV myocardial sys-
olic dysfunction is a common finding in asymp-
omatic AS (33% of our patients), affecting
articularly men, patients with concentric LV hy-
ertrophy, and high global LV load, suggesting
ombined valvular and arterial disease. A simple
-term risk score including these covariates can be
linically used in identifying patients with a high
isk of low myocardial systolic function (risk score
14). Further studies are needed to evaluate the
rognostic impact of measures of LV myocardial
ystolic dysfunction and global load in AS patients
nd thus the clinical benefit of calculating stress-
orrected midwall shortening and global LV load in
atients with asymptomatic AS.
tudy limitations. The present analysis is cross-
ectional, and the impact of different levels of global
V load on LV systolic function is assessed by
ividing the study population in tertiles of load.
ongitudinal follow-up during the planned 4-year
uration of the study will provide information about
he prognostic implications of the present findings.
easurement of stress-corrected midwall shorten-
ng was based on 2-dimensional measurements
ccording to the current recommendations (15).
owever, they assume homogenous wall thickness
n the LV, a limitation that we attempted to avoidmyocardial function in patients with Am J Cardiol 2007ients with asymmetrical hypertrophy of the septum
nd by excluding patients with coronary artery
isease and subsequent wall motion abnormalities.
O N C L U S I O N S
n patients with asymptomatic AS without diabetes
r known artery disease recruited in the SEAS
tudy, EF was generally preserved, whereas LV
yocardial dysfunction was present in 33% of
atients. LV myocardial dysfunction was particu-
arly common in patients with increased global LV
oad, and especially in the subgroup with low-flow
S, and was associated with more concentric LV
eometry, LV hypertrophy, and male sex. Assessing
V myocardial function may be helpful in identi-
ying these patients with impaired intrinsic myocar-
ial dysfunction in spite of normal EF. However,
he prognostic implication of LV myocardial dys-
unction in asymptomatic AS patients with normal
F is currently unknown and needs to be addressed
n future research.
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